Effective Drug Carrier Based on Polyethylenimine-Functionalized Bacterial Cellulose with Controllable Release Properties

2018 ◽  
Vol 1 (1) ◽  
pp. 42-50 ◽  
Author(s):  
Xiao Chen ◽  
Xuran Xu ◽  
Wenping Li ◽  
Bianjing Sun ◽  
Jun Yan ◽  
...  
2020 ◽  
Vol 248 ◽  
pp. 116745
Author(s):  
Sergey O. Solomevich ◽  
Egor I. Dmitruk ◽  
Pavel M. Bychkovsky ◽  
Alexander E. Nebytov ◽  
Tatiana L. Yurkshtovich ◽  
...  

2015 ◽  
Vol 39 (5) ◽  
pp. 3835-3844 ◽  
Author(s):  
Sachin Mane ◽  
Surendra Ponrathnam ◽  
Nayaku Chavan

Langmuir adsorption isotherm demonstrates monolayer drug loading with hyperhydrophilic three-dimensional crosslinked polymers. Furthermore, the pseudo order kinetics were also evaluated.


2017 ◽  
Vol 5 (8) ◽  
pp. 1649-1658
Author(s):  
AmiraS Eldin ◽  
◽  
ShereenM Azab ◽  
AbdallahA Shalaby ◽  
MagdaEl Maamly ◽  
...  

2020 ◽  
Vol 8 (11) ◽  
pp. 3138-3146 ◽  
Author(s):  
Dawei Li ◽  
Jin Zhou ◽  
Mingming Zhang ◽  
Yuanzheng Ma ◽  
Yanyu Yang ◽  
...  

An alendronate-loaded tetra-PEG hydrogel, as an injectable and effective drug carrier, regulates the optimized release of therapeutic cargoes to promote osteoporosis therapy and bone regeneration.


2019 ◽  
Vol 20 (19) ◽  
pp. 4919 ◽  
Author(s):  
Toru Hoshi ◽  
Masashige Suzuki ◽  
Mayu Ishikawa ◽  
Masahito Endo ◽  
Takao Aoyagi

A hollow-type spherical bacterial cellulose (HSBC) gel prepared using conventional methods cannot load particles larger than the pore size of the cellulose nanofiber network of bacterial cellulose (BC) gelatinous membranes. In this study, we prepared a HSBC gel encapsulating target substances larger than the pore size of the BC gelatinous membranes using two encapsulating methods. The first method involved producing the BC gelatinous membrane on the surface of the core that was a spherical alginate gel with a diameter of 2 to 3 mm containing the target substances. With this method, the BC gelatinous membrane was biosynthesized using Gluconacetobacter xylinus at the interface between the cell suspension attached onto the alginate gel and the silicone oil. The second method involved producing the BC gel membrane on the interface between the silicone oil and cell suspension, as well as the spherical alginate gel with a diameter of about 1 mm containing target substances. After the BC gelatinous membrane was biosynthesized, an alginate gel was dissolved in a phosphate buffer to prepare an HSBC gel with the target substances. These encapsulated substances could neither pass through the BC gelatinous membrane of the HSBC gel nor leak from the interior space of the HSBC gel. These results suggest that the HSBC gel had a molecular sieving function. The HSBC gel walls prepared using these methods were observed to be uniform and would be useful for encapsulating bioactive molecules, such as immobilized enzymes in HSBC gel, which is expected to be used as a drug carrier.


2018 ◽  
Vol 31 (3) ◽  
pp. 457 ◽  
Author(s):  
E. H. Zhou ◽  
R. Wang ◽  
J. Wu ◽  
S. W. Qiu ◽  
J. Q. Liu ◽  
...  

2019 ◽  
Vol 25 (34) ◽  
pp. 3692-3701 ◽  
Author(s):  
Hanif Ullah ◽  
Munair Badshah ◽  
Alexandra Correia ◽  
Fazli Wahid ◽  
Hélder A. Santos ◽  
...  

Background: Bacterial cellulose (BC) has recently attained greater interest in various research fields, including drug delivery for biomedical applications. BC has been studied in the field of drug delivery, such as tablet coating, controlled release systems and prodrug design. Objective: In the current work, we tested the feasibility of BC as a drug carrier in microparticulate form for potential pharmaceutical and biomedical applications. Method : For this purpose, drug-loaded BC microparticles were prepared by simple grinding and injection moulding method through regeneration. Model drugs, i.e., cloxacillin (CLX) and cefuroxime (CEF) sodium salts were loaded in these microparticles to assess their drug loading and release properties. The prepared microparticles were evaluated in terms of particle shapes, drug loading efficiency, physical state of the loaded drug, drug release behaviour and antibacterial properties. Results: The BC microparticles were converted to partially amorphous state after regeneration. Moreover, the loaded drug was transformed into the amorphous state. The results of scanning electron microscopy (SEM) showed that microparticles had almost spherical shape with a size of ca. 350-400 μm. The microparticles treated with higher drug concentration (3%) exhibited higher drug loading. Keeping drug concertation constant, i.e., 1%, the regenerated BC (RBC) microparticles showed higher drug loading (i.e., 37.57±0.22% for CEF and 33.36±3.03% for CLX) as compared to as-synthesized BC (ABC) microparticles (i.e., 9.46±1.30% for CEF and 9.84±1.26% for CLX). All formulations showed immediate drug release, wherein more than 85% drug was released in the initial 30 min. Moreover, such microparticles exhibited good antibacterial activity with larger zones of inhibition for drug loaded RBC microparticles as compared to corresponding ABC microparticles. Conclusion : Drug loaded BC microparticles with immediate release behaviour and antibacterial activity were fabricated. Such functionalized microparticles may find potential biomedical and pharmaceutical applications.


2013 ◽  
Vol 14 (8) ◽  
pp. 879-890 ◽  
Author(s):  
En Luo ◽  
Guodong Song ◽  
Yunfeng Li ◽  
Pengwei Shi ◽  
Jing Hu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document